title: Hytrin treatment of hypertension and benign prostatic hyperplasia.
abstract: BPH is a diagnosis that needs to be considered and evaluated in older male renal disease/failure patients. Rather than proceeding to the invasive treatment options, Hytrin should be considered as the treatment of choice. Not only can it relieve the symptoms of BPH, but also be an effective treatment for hypertension. Ongoing assessment, observation for side effects, monitoring for lower urinary tract dysfunction, along with patient education and documentation are the responsibilities of nephrology nurses.
authors.forename: L
authors.initials: L
authors.lastname: Moon
authors.forename: S
authors.initials: S
authors.lastname: Pfettscher
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D011224:Prazosin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000188:drug therapy*
chemical_list: D000317:Adrenergic alpha-Antagonists; C041226:Terazosin; D011224:Prazosin